Adaptive Biotechnologies Corp vs TKO Group Holdings Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while TKO Group Holdings Inc trades at $194.36 (market cap $14.24B). The key difference: TKO Group Holdings Inc is far larger — about 3.5× Adaptive Biotechnologies Corp's market cap, and TKO Group Holdings Inc pays a 1.6% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | TKO | |
|---|---|---|
Market Cap | $4.04B | $14.24B |
Sector | Health | Technology |
52-Week High | $25.45 | $224.96 |
52-Week Low | $12.30 | $176.49 |
Enterprise Value | $4.10B | $18.60B |
Dividend Yield | — | 1.6% |
Trailing returns across standard periods
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →TKO Group Holdings is a premium sports and entertainment company that serves as the parent entity for the Ultimate Fighting Championship (UFC) and World Wrestling Entertainment (WWE). Formed through a seismic merger orchestrated by Endeavor, TKO leverages a combined global fanbase of over 1 billion to drive massive revenue through media rights, global live events, and a unified sponsorship platform, effectively monopolizing the professional combat sports landscape.
Read more on TKO →